trending Market Intelligence /marketintelligence/en/news-insights/trending/_-fQqDo61-Jl8yNPKCQJzQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Valeant closes $750M debt offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Valeant closes $750M debt offering

Valeant Pharmaceuticals International Inc. closed an offering of $750 million of 5.50% senior secured notes due 2025.

Net proceeds were used, along with cash on hand, to prepay a portion of company's outstanding series F tranche B term loan facilities due 2022 and to pay related fees and expenses.

After the closing, Valeant successfully completed the repricing of its series F tranche B term loan. The amendment reduces the annual interest rate on the facilities by 1.25% and makes certain other changes.